Skip to content

Study of the Impact of Gastric Interoceptive Signals on the Body Schema Via the Water Load Test II ( GIBS)

Study of the Impact of Gastric Interoceptive Signals on the Body Schema Via the Water Load Test II

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07633652
Acronym
GIBS
Enrollment
108
Registered
2026-06-08
Start date
2025-02-04
Completion date
2025-10-02
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

body schema, water load test II, gastric interoceptive signals

Brief summary

The aim of this study was to evaluate whether gastric interoceptive information has a direct impact on the motor and tactile dimensions of the body schema.

Interventions

SKIN test

OTHERMOVE

test MOVE

OTHERwater load test II

water load test II

OTHERWater load test questionnary

Water load test questionnary

Sponsors

Centre Hospitalier Metropole Savoie
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Healthy Volunteers without pathology

Exclusion criteria

* pregnant,

Design outcomes

Primary

MeasureTime frameDescription
modification of the body schema in its motor and tactile dimensionsbefore and within 10 minutes after gastric interoceptive activation task (day 1)The primary endpoint is composite and corresponds to the two differences in SKIN and MOVE scores, measured before and after the gastric interoceptive activation task, which assess the integrity of the body pattern. * The SKIN score is the average difference (in mm) between the actual deviation applied to the shoulder and belly skin and the estimated deviation reported by the participant. * MOVE score is the average ratio between the minimum distance (in mm) between virtual balls thrown at a person's shoulders and belly and from which they are avoided, and the actual morphology of this person at the point where the bullets pass (actual body width in mm).

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 9, 2026